US Stock MarketDetailed Quotes

EDSA Edesa Biotech

Watchlist
  • 2.5300
  • -0.0300-1.17%
Trading Mar 25 15:01 ET
17.69MMarket Cap-1.35P/E (TTM)

Edesa Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.01%1.6M
-26.91%6.32M
-45.93%967.18K
-17.83%1.7M
-20.50%1.92M
-26.98%1.74M
-50.87%8.64M
-36.94%1.79M
-64.39%2.06M
-47.31%2.41M
Selling and administrative expenses
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
12.93%1.15M
-12.06%4.43M
35.87%1.42M
-16.91%1.04M
-37.85%952.39K
-General and administrative expense
-23.77%878.87K
-6.67%4.13M
-36.42%900.53K
-0.33%1.04M
9.63%1.04M
12.93%1.15M
-12.06%4.43M
35.87%1.42M
-16.91%1.04M
-37.85%952.39K
Research and development costs
44.77%1.02M
-39.89%2.88M
-89.11%103.87K
-12.51%897.31K
-19.33%1.18M
-48.10%704.46K
-64.05%4.79M
-46.85%953.4K
-77.45%1.03M
-52.08%1.46M
Other operating expenses
-149.26%-301.2K
-20.18%-698.28K
---37.22K
---236.23K
---304K
---120.83K
25.53%-581.04K
----
----
----
Operating profit
8.01%-1.6M
26.91%-6.32M
45.93%-967.18K
17.83%-1.7M
20.50%-1.92M
26.98%-1.74M
50.87%-8.64M
36.94%-1.79M
64.39%-2.06M
47.31%-2.41M
Net non-operating interest income expense
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
23.34%60.97K
356.29%289.85K
99.09%71.95K
372.39%82.75K
2,187.03%85.72K
Non-operating interest income
-97.27%1.67K
-47.04%153.5K
-77.08%16.49K
-60.31%32.85K
-49.61%43.19K
23.34%60.97K
356.29%289.85K
99.09%71.95K
372.39%82.75K
2,187.03%85.72K
Other net income (expense)
-659.21%-21.43K
71.13%-6.28K
-210.07%-11.36K
-40.28%-4.84K
246.76%12.75K
52.50%-2.82K
-2.97%-21.74K
73.33%-3.66K
50.79%-3.45K
-392.75%-8.69K
Gain on sale of security
-659.21%-21.43K
3.22%-21.04K
-210.07%-11.36K
-40.28%-4.84K
76.77%-2.02K
52.50%-2.82K
-2.97%-21.74K
73.33%-3.66K
50.79%-3.45K
-392.75%-8.69K
Other non- operating income (expenses)
----
--14.77K
--0
----
--14.77K
----
----
----
----
----
Income before tax
3.65%-1.62M
26.33%-6.17M
44.08%-962.05K
15.96%-1.67M
20.27%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.92%-2.33M
Income tax
0.00%800
0
0
0.00%800
0.00%800
0
0
0.00%800
Net income
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
Net income continuous Operations
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
Minority interest income
Net income attributable to the parent company
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.65%-1.62M
26.32%-6.17M
44.08%-962.05K
15.96%-1.67M
20.26%-1.86M
28.11%-1.68M
52.28%-8.37M
38.86%-1.72M
65.70%-1.98M
48.91%-2.33M
Basic earnings per share
11.11%-0.48
-361.09%-1.93
48.16%-0.29
23.53%-0.52
29.27%-0.58
39.33%-0.54
95.00%-0.4186
48.68%-0.5594
73.75%-0.68
64.50%-0.82
Diluted earnings per share
11.11%-0.48
-361.09%-1.93
48.16%-0.29
23.53%-0.52
29.27%-0.58
39.33%-0.54
95.00%-0.4186
48.68%-0.5594
73.75%-0.68
64.50%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.01%1.6M-26.91%6.32M-45.93%967.18K-17.83%1.7M-20.50%1.92M-26.98%1.74M-50.87%8.64M-36.94%1.79M-64.39%2.06M-47.31%2.41M
Selling and administrative expenses -23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M12.93%1.15M-12.06%4.43M35.87%1.42M-16.91%1.04M-37.85%952.39K
-General and administrative expense -23.77%878.87K-6.67%4.13M-36.42%900.53K-0.33%1.04M9.63%1.04M12.93%1.15M-12.06%4.43M35.87%1.42M-16.91%1.04M-37.85%952.39K
Research and development costs 44.77%1.02M-39.89%2.88M-89.11%103.87K-12.51%897.31K-19.33%1.18M-48.10%704.46K-64.05%4.79M-46.85%953.4K-77.45%1.03M-52.08%1.46M
Other operating expenses -149.26%-301.2K-20.18%-698.28K---37.22K---236.23K---304K---120.83K25.53%-581.04K------------
Operating profit 8.01%-1.6M26.91%-6.32M45.93%-967.18K17.83%-1.7M20.50%-1.92M26.98%-1.74M50.87%-8.64M36.94%-1.79M64.39%-2.06M47.31%-2.41M
Net non-operating interest income expense -97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K23.34%60.97K356.29%289.85K99.09%71.95K372.39%82.75K2,187.03%85.72K
Non-operating interest income -97.27%1.67K-47.04%153.5K-77.08%16.49K-60.31%32.85K-49.61%43.19K23.34%60.97K356.29%289.85K99.09%71.95K372.39%82.75K2,187.03%85.72K
Other net income (expense) -659.21%-21.43K71.13%-6.28K-210.07%-11.36K-40.28%-4.84K246.76%12.75K52.50%-2.82K-2.97%-21.74K73.33%-3.66K50.79%-3.45K-392.75%-8.69K
Gain on sale of security -659.21%-21.43K3.22%-21.04K-210.07%-11.36K-40.28%-4.84K76.77%-2.02K52.50%-2.82K-2.97%-21.74K73.33%-3.66K50.79%-3.45K-392.75%-8.69K
Other non- operating income (expenses) ------14.77K--0------14.77K--------------------
Income before tax 3.65%-1.62M26.33%-6.17M44.08%-962.05K15.96%-1.67M20.27%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.92%-2.33M
Income tax 0.00%800000.00%8000.00%800000.00%800
Net income 3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M
Net income continuous Operations 3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M
Minority interest income
Net income attributable to the parent company 3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.65%-1.62M26.32%-6.17M44.08%-962.05K15.96%-1.67M20.26%-1.86M28.11%-1.68M52.28%-8.37M38.86%-1.72M65.70%-1.98M48.91%-2.33M
Basic earnings per share 11.11%-0.48-361.09%-1.9348.16%-0.2923.53%-0.5229.27%-0.5839.33%-0.5495.00%-0.418648.68%-0.559473.75%-0.6864.50%-0.82
Diluted earnings per share 11.11%-0.48-361.09%-1.9348.16%-0.2923.53%-0.5229.27%-0.5839.33%-0.5495.00%-0.418648.68%-0.559473.75%-0.6864.50%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More